DataMEDS AI, Inc. (MEDS) vs Mangoceuticals, Inc. (MGRX)
A side-by-side comparison of DataMEDS AI, Inc. and Mangoceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MEDS
DataMEDS AI, Inc.
$3.07HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MGRX
Mangoceuticals, Inc.
$0.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MEDS vs MGRX
growth of $100 · dividends reinvested · last 4yMEDS -39.5% (-11.8%/yr)MGRX -99.3% (-71.1%/yr)MEDS compounded faster over this window
Log scale — wide-divergence pair
MEDS MGRX
MEDS vs MGRX: by the numbers
- •MEDS is the larger company ($8M vs $8M market cap).
- •Both run net losses; MEDS's is the smaller (-1100.30% vs -4791.48% net margin).
Metrics side by side
Valuation
| Metric | MEDS | MGRX |
|---|---|---|
| P/S ratio | 1.00 | 24.22 |
| P/B ratio | N/A | 0.61 |
Profitability
| Metric | MEDS | MGRX |
|---|---|---|
| Gross margin | -41.30% | 54.43% |
| Operating margin | -347.91% | -4200.46% |
| Net margin | -1100.30% | -4791.48% |
| ROE | N/A | -120.58% |
| ROIC | -439.90% | -102.91% |
Growth (annualized)
| Metric | MEDS | MGRX |
|---|---|---|
| Total return CAGR (5Y) | -45.88% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.